Qingwei Liu
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
High-yield production of immunogenic PV3 virus-like particle in yeast.
Journal: Antiviral research
Published: June 01, 2026
Standardized neutralizing antibody assay for Coxsackievirus A10 in clinical trial: A framework for multivalent hand, foot, and mouth disease vaccine evaluation.
Journal: Human vaccines & immunotherapeutics
Published: March 19, 2026
Safety, tolerability and immunogenicity of a quadrivalent recombinant norovirus vaccine (Pichia pastoris) in participants six weeks of age or older: Phase I/IIa trial.
Journal: Emerging microbes & infections
Published: September 22, 2025
Development of an oral gut-targeted rabies virus-like particles (RVLPs) vaccine with mucosal immune adjuvant LTB via delivering of localized-release microparticles.
Journal: Emerging microbes & infections
Published: June 06, 2025
Vaccine Potency and Structure of Yeast-Produced Polio Type 2 Stabilized Virus-like Particles.
Journal: Vaccines
Published: August 12, 2024
Molecular mechanism of antibody neutralization of coxsackievirus A16.
Journal: Nature communications
Published: June 25, 2022
Identification of Human Norovirus GII.3 Blockade Antibody Epitopes.
Journal: Viruses
Published: September 12, 2021
Identification of a blockade epitope of human norovirus GII.17.
Journal: Emerging microbes & infections
Published: April 30, 2021
Two immunogenic recombinant protein vaccine candidates showed disparate protective efficacy against Zika virus infection in rhesus macaques.
Journal: Vaccine
Published: September 20, 2020
Last Updated: 09/26/2026